Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
18%
OVERLAP
BY WEIGHT
15
# OF OVERLAPPING
HOLDINGS
ZHU.TO
81
HOLDINGS
19%
ALSO IN MEDX.TO
MEDX.TO
22
HOLDINGS
83%
ALSO IN ZHU.TO
SECTOR DRIFT (ZHU.TO minus MEDX.TO)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in ZHU.TO |
Weight in MEDX.TO |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 1.3% | 5.5% | 1.3% |
|
MERCK & CO. INC. | 1.3% | 5.2% | 1.3% |
|
VERTEX PHARMACEUTICALS INC | 1.3% | 5.2% | 1.3% |
|
BRISTOL-MYERS SQUIBB CO | 1.2% | 5.1% | 1.2% |
|
JOHNSON & JOHNSON | 1.2% | 5.1% | 1.2% |
ZHU.TO Overweight Relative to MEDX.TO
|
HUMANA INC | 2.2% |
|
REVOLUTION MEDICINES, INC. | 1.9% |
|
UNITEDHEALTH GROUP INC | 1.8% |
|
ELEVANCE HEALTH INC | 1.8% |
|
CENTENE CORP | 1.7% |
|
DAVITA INC | 1.7% |
 |
JAZZ PHARMACEUTICALS PLC | 1.6% |
|
NEUROCRINE BIOSCIENCES INC | 1.6% |
|
WEST PHARMACEUTICAL SERVICES | 1.6% |
|
EXELIXIS INC | 1.6% |
ZHU.TO Underweight Relative to MEDX.TO
 |
NOVO-NORDISK A/S-SPONS ADR | -6.3% |
 |
ASTRAZENECA PLC | -5.2% |
 |
NOVARTIS AG | -5.1% |
|
ELI LILLY & CO | -4.2% |
|
MERCK & CO. INC. | -4.0% |
|
VERTEX PHARMACEUTICALS INC | -3.9% |
|
BRISTOL-MYERS SQUIBB CO | -3.9% |
|
JOHNSON & JOHNSON | -3.9% |
|
PFIZER INC | -3.9% |
|
ABBVIE INC | -3.8% |